Implantation success as determined by blastocoel fluid components
US12305227B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2019 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Oct 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The current disclosure explains that cfDNA levels, specific gene expression profiles (assessed via altered mRNA levels of specific gene transcripts), specific protein levels, and potentially noncoding RNAs in blastocoel fluid are all factors that can be used to forecast/determine the implantation potential in IVF patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.